Stereological and histopathological evaluation of doxorubicin-induced toxicity in female rats' ovary and uterus and palliative effects of quercetin and vitamin E

Hum Exp Toxicol. 2020 Dec;39(12):1710-1724. doi: 10.1177/0960327120937329. Epub 2020 Jul 15.

Abstract

Doxorubicin (DOX) is a widely used chemotherapeutic agent with demonstrated reproductive toxicity. This study sought to determine the DOX-induced toxicity in the ovary and uterus and the preventive effects of quercetin (QCT) and vitamin E (Vit.E). Female rats were divided into six groups as follows: control, QCT (20 mg/kg), Vit.E (200 mg/kg), DOX (accumulative 15 mg/kg), DOX/QCT, and DOX/Vit.E. After 3 weeks, the toxicity of DOX in ovarian and uterine tissues and the potential palliative effects of QCT and Vit.E were evaluated by histopathological-stereological methods. The findings indicate a dramatic decline in the number of ovarian follicles (p < 0.001), ovarian and its associated structures volume, the volume of the uterus, its layers, and related structures (p < 0.05). Coadministration of QCT and Vit.E with DOX-treated rats demonstrated an alleviative effect on most of the studied parameters. Nevertheless, few adverse effects were recognized concerning these antioxidants administration (p < 0.05). In conclusion, the findings of this study support the protective role of these dietary supplements in the prevention of DOX-induced toxicity in uterine and ovarian tissues.

Keywords: Chemotherapy; cancer; doxorubicin; infertility; toxicity.

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / toxicity*
  • Antioxidants / therapeutic use*
  • Doxorubicin / toxicity*
  • Female
  • Ovary / drug effects*
  • Ovary / pathology
  • Quercetin / therapeutic use*
  • Rats, Sprague-Dawley
  • Uterus / drug effects*
  • Uterus / pathology
  • Vitamin E / therapeutic use*
  • Vitamins / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Antioxidants
  • Vitamins
  • Vitamin E
  • Doxorubicin
  • Quercetin